These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3299673)

  • 21. [Vitamin D and osteoporosis].
    Hoszowski K
    Pol Tyg Lek; 1995 Nov; 50(44-47):53-5. PubMed ID: 8643430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1,25-Dihydroxycalciferol and calcium therapy in osteoporosis with calcium malabsorption. Dose response relationship of calcium absorption and indices of bone turnover.
    Need AG; Horowitz M; Philcox JC; Nordin BE
    Miner Electrolyte Metab; 1985; 11(1):35-40. PubMed ID: 3838358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Primary hypoparathyroidism resistant to treatment with vitamin D3, 25-hydroxycholecalciferol and dihydrotachysterol. Efficacy of treatment with 1 alpha,25-dihyroxycholecalciferol].
    Sanmartí Sala A; Recas Planellas I; Tresánchez Trías JM; Mesa Manteca J; Bonal Bastons J; Foz Sala M
    Med Clin (Barc); 1983 Apr; 80(12):541-4. PubMed ID: 6306361
    [No Abstract]   [Full Text] [Related]  

  • 24. [Anabolizing agents and phosphocalcic metabolism].
    Eisinger J; D'Omezon Y; Laponche AM; Recordier AM
    Mars Med; 1972; 109(1):31-3. PubMed ID: 5018830
    [No Abstract]   [Full Text] [Related]  

  • 25. Vitamin D and its metabolites. Advances in the diagnosis and treatment of rickets.
    Tojo R; Pavon P; Antelo J; Mourino A
    Acta Vitaminol Enzymol; 1982; 4(1-2):1-11. PubMed ID: 6289643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Current trends of phosphotherapy].
    Recordier AM; Eisinger J
    Mars Med; 1970; 107(11):873-7. PubMed ID: 4922773
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of vitamin D on tuberculosis and HIV replication depends on conversion to calcitriol and concentration.
    Eisenhut M
    Am J Respir Crit Care Med; 2009 Oct; 180(8):795; author reply 795-6. PubMed ID: 19805798
    [No Abstract]   [Full Text] [Related]  

  • 28. [Does calcifediol replace vitamin D as a preventive and therapeutic agent?].
    Burmeister W
    Monatsschr Kinderheilkd; 1984 Jul; 132(7):556-7. PubMed ID: 6088972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Glucocorticoids and calcium metabolism regulation].
    Babarykin DA
    Ter Arkh; 1984; 56(3):137-41. PubMed ID: 6372148
    [No Abstract]   [Full Text] [Related]  

  • 30. Vitamin D and its metabolites in the treatment of osteoporosis.
    Burckhardt P; Lamy O
    Osteoporos Int; 1998; 8 Suppl 2():S40-4. PubMed ID: 10197182
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of hypercaliciuria in calcium diabetes and in idiopathic osteoporosis in young subjects with a new chlorothiazide: methyclothiazide].
    Bordier P; de Sèze S; Hioco D
    Sem Ther; 1968 Apr; 44(4):238-41. PubMed ID: 5759696
    [No Abstract]   [Full Text] [Related]  

  • 32. Heterogeneity in osteosarcoma cell lines and the biological effects of the chemical structure of 25-hydroxyvitamin D₃ and 1 a,25 dihydroxyvitamin D₃.
    Dokos C; Groll AH
    J Orthop Res; 2012 Dec; 30(12):2052; author reply 2052-3. PubMed ID: 22653562
    [No Abstract]   [Full Text] [Related]  

  • 33. Hypocalciuric effect of benzothiazides.
    Moens C; Wauters M
    Acta Rheumatol Scand; 1966; 12(3):228-33. PubMed ID: 5957873
    [No Abstract]   [Full Text] [Related]  

  • 34. Rationale for active vitamin D analog therapy in senile osteoporosis.
    Akesson K; Lau KH; Baylink DJ
    Calcif Tissue Int; 1997 Jan; 60(1):100-5. PubMed ID: 9030489
    [No Abstract]   [Full Text] [Related]  

  • 35. Calcitriol and osteoporosis.
    Nordin BE; Need AG; Morris HA; Horowitz M
    Ann Intern Med; 1989 Oct; 111(8):689. PubMed ID: 2627214
    [No Abstract]   [Full Text] [Related]  

  • 36. Calcitriol for osteoporosis.
    Need AG; Morris HA; Nordin BE
    Lancet; 1990 May; 335(8700):1291. PubMed ID: 1971370
    [No Abstract]   [Full Text] [Related]  

  • 37. Normal serum concentrations of 1,25 dihydroxyvitamin D in osteoporosis.
    Cantatore FP; Carrozzo M
    Clin Rheumatol; 1990 Jun; 9(2):210-3. PubMed ID: 2390850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapeutic use of vitamin D metabolites. II. Principal indications].
    Kuntz D
    Rev Rhum Mal Osteoartic; 1987 Apr; 54(4):329-38. PubMed ID: 3299673
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of calcium and phosphorus metabolism disorders with vitamin D metabolites. Preliminary results].
    Vuković D; Stojanov LJ; Banićević M; Bogdanović R
    Srp Arh Celok Lek; 1980 Sep; 108(9):909-21. PubMed ID: 6895421
    [No Abstract]   [Full Text] [Related]  

  • 40. [Vitamin D and its active metabolites in the prevention and treatment of osteoporosis].
    Rivier E
    Rev Med Suisse Romande; 1998 Mar; 118(3):267-77. PubMed ID: 9594604
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.